恩替卡韦
医学
胃肠病学
肝活检
内科学
肝硬化
HBeAg
纤维化
活检
拉米夫定
队列
核苷类似物
乙型肝炎病毒
免疫学
乙型肝炎表面抗原
核苷
病毒
生物
生物化学
作者
Ting‐Tsung Chang,Yun‐Fan Liaw,Shun-Sheng Wu,Eugene R. Schiff,Kwang‐Hyub Han,Ching‐Lung Lai,Rifaat Safadi,Samuel S. Lee,Waldemar Halota,Zachary Goodman,Yun-Chan Chi,Hui Zhang,R. Hindes,Uchenna H. Iloeje,S. P. Beebe,Bruce Kreter
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2010-06-02
卷期号:52 (3): 886-893
被引量:982
摘要
The majority of nucleoside-naive patients with CHB who were treated with entecavir in this long-term cohort achieved substantial histological improvement and regression of fibrosis or cirrhosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI